<DOC>
	<DOCNO>NCT00970437</DOCNO>
	<brief_summary>The purpose study compare efficacy Cognitive Behavioural Analysis System Psychotherapy ( CBASP ) non-specific System Supportive Psychotherapy ( SYSP ) early onset chronically depressive .</brief_summary>
	<brief_title>A Comparison Cognitive Behavioral Analysis System Psychotherapy ( CBASP ) System Supportive Psychotherapy ( SYSP ) Early Onset Chronic Depression</brief_title>
	<detailed_description>Effective treatment strategy chronic depression urgently need since common particularly disable disorder , also consider treatment resistant clinician . There study chronic depression indicate traditional intervention effective acute , episodic depression . In addition , study methodological weakness , short course psychotherapy . Usually , chronic depression begin early life , often associate early interpersonal trauma , result even substantial human capital loss late-onset group . Furthermore , show weak response medication high rate relapse initial response . With present multicentre study , efficacy specific psychotherapy chronic depression ( Cognitive Behavioural Analysis System Psychotherapy/CBASP ) compare non-specific System Supportive Psychotherapy/SYSP early onset chronically depressives . CBASP fair well one large trial never directly compare non-specific psychotherapeutic control . Another innovative aspect study use extend course psychotherapy ( 32 session ) . Primary hypothesis : CBASP effective reduce depressive symptom SYSP .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . DSMIV criterion current episode chronic MDD , MDD superimpose preexist dysthymic disorder recurrent MDD incomplete remission episode patient current MDD total duration least 2 year . 2 . Early onset disorder accord DSMIV ( onset age 21 ) 3 . Age 18 65 4 . A score least 20 24item HRSD screening , 2week drugfree period , baseline 5 . Fluent German language 6 . Provide informed consent 1 . Acute risk suicide ( oppose suicidal thought ) assess accord clinical practice guideline . Suicidal patient eligible , long outpatient treatment deem safe clinician . 2 . A history psychotic symptom , bipolar disorder , organic brain disorder 3 . A primary diagnosis another axis I disorder include anxiety disorder ( e.g . Posttraumatic Stress Disorder ) , severe substancerelated abuse dependence disorder evaluate SCIDI 4 . Antisocial , schizotypical , borderline personality disorder ( SCIDII ) ; 5 . Severe cognitive impairment 6 . Absence response previous adequate trial CBASP , and/or SYSP 7 . Other ongoing psychotherapy medication 8 . A serious medical condition ( i.e . history seizure , severe head trauma , stroke heart attack within six month study begin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>